Dr. Kristen Mitchell joined the faculty of Boise State University in January 2008. She earned her B.S. in Microbiology from Idaho State University in 1995, and her Ph.D. in Pharmacology/Toxicology from the Department of Pharmaceutical Sciences at Washington State University in Pullman, Washington in 2003. From 2003-2007, Dr. Mitchell conducted postdoctoral training in molecular toxicology at the University of Texas Medical Branch in Galveston, Texas. Dr. Mitchell's research interests focus on pharmacology and toxicology of the aryl hydrocarbon receptor (AhR). Specific research areas include immunotoxicity and inflammation associated with AhR ligands, and the role of the AhR in cell cycle regulation. Her research is currently supported by the NIH through grants from the Idaho Idea Network of Biomedical Research Excellence (INBRE), the Institute of Translational Health Sciences (ITHS), and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).